Home Mylan skeptical of rumored Teva bid; hasn't received offer
 

Keywords :   


Mylan skeptical of rumored Teva bid; hasn't received offer

2015-04-17 22:51:44| Biotech - Topix.net

Generic drugmaker Mylan, citing media speculation that Teva Pharmaceutical may be eyeing it as a takeover target, says it doubts that regulators would approve such a deal and says it is committed to its current strategy as a stand-alone company. In a news release Friday, Mylan said that it hasn't received an offer and described the idea that Teva might want to buy it as a rumor.

Tags: offer received bid skeptical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.05Is Zimbabwe zigzagging into further currency chaos?
05.05Why mortgage rates are going up, not down
04.05This Week in Agribusiness, May 4, 2024
04.05Weekly Recap: Sherwin-Williams, BASF, Abrafati Top This Weeks Stories
03.05'Garden floods show need to work with nature'
03.05Worst-ever job interviews: 'We had to crawl and moo'
03.05Have the wheels come off for Tesla?
03.05BW Converting focuses on time, energy and cost savings at INFOFLEX
More »